DISC1 and schizophrenia: In clinical trials, DISC1 missense variants have been found in patients affected by schizophrenia with a form of ultra-resistance to treatment, suggesting that DISC1 variants may have a functional influence on the mechanisms of action of antipsychotics and treatment response [255].